Chronic Kidney Disease in Older Adults. Consensus Statement of Russian Association of Gerontologists and Geriatricians, Scientific Society of Nephrologists of Russia and Eurasian Association of Therapists
-
Published:2024-01-17
Issue:1
Volume:
Page:6-20
-
ISSN:2686-8709
-
Container-title:Russian Journal of Geriatric Medicine
-
language:
-
Short-container-title:Rossiiskii zhurnal geriatricheskoi meditsiny
Author:
Tkacheva O. N.1ORCID, Kotovskaya Yu. V.1ORCID, Bobkova I. N.2ORCID, Shutov A. M.3ORCID, Villevalde S. V.4ORCID, Efremova E. V.3ORCID, Runikhina N. K.1ORCID, Eruslanova K. A.1ORCID, Arutyunov G. P.5ORCID, Batyushin M. M.6ORCID, Frolova E. V.7ORCID
Affiliation:
1. Pirogov National Research Medical University, Russian Gerontology Research and Clinical Centre 2. Tareev Rheumatology, Nephrology and Occupational Pathology Clinic, University Clinical Hospital No. 3 3. Ulyanovsk State University 4. Almazov National Medical Research Centre 5. Pirogov National Research Medical University 6. Rostov State Medical University 7. The North-Western State medical University named after I.I. Mechnikov
Abstract
The prevalence of chronic kidney disease (CKD) increases with age, but CKD is often underdiagnosed in older adults and regarded as age-related changes of kidney function. Screening for CKD is mandatory in older adults and should include estimated glomerular filtration rate (eGFR) using both the CKD EPI creatinine-based formula and the albumin/creatinine ratio in a urine spot sample. In older adults the diagnostic criteria of CKD are the same as in younger subjects. CKD is associated with advanced ageing and requires careful assessment of geriatric syndromes. Renal function should be assessed at least annually, considering a rate of decline in eGFR greater than 1 ml/min/1.73 m2 per year as significant. Older adults with CKD are characterized by high comorbidity; risk factors for CKD and geriatric syndromes overlap. CKD should be considered among a number of comorbid conditions that increase the risk of deterioration of geriatric status and underline the need for multidisciplinary management based on a comprehensive geriatric assessment. Patients with eGFR <60 ml/min/1.73 m2 should be considered at high risk for renal and extrarenal adverse drug effects. In these patients, inappropriate medications, supplements, and vitamins should be carefully identified and corrected using STOPP/START criteria. eGFR and estimated creatinine clearance should be carefully monitored during treatment with drugs that can potentially affect renal function and/or the dose of which is adjusted based on renal function, as well as during acute illness or exacerbation of chronic conditions.
Publisher
Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology
Reference48 articles.
1. Клинические рекомендации «Хроническая болезнь почек», https://cr.minzdrav.gov.ru/recomend/469_2 2. Moiseev V.C., Mukhin N.A., Smirnov A.V., Kobalava J.D., Bobkova I.N., Villevalde S.V., Yefremovtseva M.A., Kozlovskaya L.V., Shvetsov M.Yu., Shestakova M.V., Arutyunov G.P., Boytsov S.A., Galyavich A.S., Greenstein Y.I., Dobronravov V.A., Drapkina O.M., Ermolenko V.M., Karpov Yu.A., Kayukov I.G., Kotovsky J.V., Kukharchuk V.V., Martynov A.I., Morozova T.E., Oganov R.G., Podzolkov V.I., Rozhinskaya L.Y., Tereshchenko S.N., Fomin V.V., Khirmanov V.N., Chazova I.E., Shamkhalova M.S., Shilov E.M., Shlyakhto E.V., Shutov A.M. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Russian Journal of Cardiology. 2014;(8):7-37. (In Russ.) 3. de Boer IH. Chronic kidney disease—a challenge for all ages. JAMA. 2012 Dec 12;308(22):2401-2. doi: 10.1001/jama.2012.30761 4. Farrington K, Covic A, Nistor I, Aucella F, Clyne N, De Vos L, Findlay A, Fouque D, Grodzicki T, Iyasere O, Jager KJ, Joosten H, Macias JF, Mooney A, Nagler E, Nitsch D, Taal M, Tattersall J, Stryckers M, van Asselt D, Van den Noortgate N, van der Veer S, van Biesen W. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m 2 ): a summary document from the European Renal Best Practice Group. Nephrol Dial Transplant. 2017 Jan 1;32(1):9-16. doi: 10.1093/ndt/gfw411 5. Delanaye P, Schaeffner E, Cozzolino M, Langlois M, Plebani M, Ozben T, Cavalier E. The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chem Lab Med. 2022 Oct 24;61(1):44-47. doi: 10.1515/cclm-2022-0928
|
|